(WXIN) — The company behind Banana Boat is recalling more of its sunscreen products due to the presence of a cancer-causing chemical.
On January 27, Edgewell Personal Care Company announced that it is expanding its nationwide recall of hair and scalp sun protection sprays that were originally issued in July 2022. The recall was initiated because an inspection revealed that unexpected levels of benzene came from motor fuel even though is not an ingredient in any Banana Boat products.
The recall includes an additional batch of the recalled hair and scalp sunscreen spray. The company said no other batches or products are being recalled. The products subject to the recall are:
The US Food and Drug Administration (FDA) has said that benzene is classified as a human carcinogen that can potentially lead to cancers, including leukemia and blood cancer of the blood marrow. It can also cause life-threatening blood disorders.
The Centers for Disease Control and Prevention says benzene works by causing cells to not function properly. For example, it can cause the bone marrow to not produce enough red blood cells. It can also damage the immune system by changing the level of antibodies in the blood and causing a loss of white blood cells.
The CDC says people are exposed to benzene every day, including from tobacco smoke, gas stations, exhaust fumes and industrial emissions. Indoors, people can be exposed to benzene from glues, paints, furniture wax, and detergents.
The company says daily exposure to benzene in the recalled products is not expected to cause adverse health effects, according to an independent health assessment using established exposure modeling guidelines.
Anyone with a recalled product should stop using it and dispose of it. I can get a refund by contacting Edgewell Personal Care at 1-888-686-3988 Monday through Friday, 9 a.m. to 6 p.m. I can also visit www.bananaboat.com for more information and to find out how to get reimbursed for eligible products.
Anyone who has experienced adverse reactions or quality problems from using the product should report it to the FDA’s MedWatch Adverse Event Reporting Program in the following ways: